STIM 0.75 (-57.87%)
US64131A1051Medical Diagnostics & ResearchDiagnostics & Research

Neuronetics (STIM) Competitor Comparison

We are evaluating the key criteria listed to compare Neuronetics (STIM) against its competitors in the Diagnostics & Research industry.

Linearity 3 years - STIM ranking 40 / 58

These are the competitors of Neuronetics in the industry Diagnostics & Research ranked by linearity 3 years
1. Quest Diagnostics DGX
255.6
2. Danaher DHR
43.49
3. IQVIA Holdings IQV
43.17
4. Ortho Clinical Diagnostics Holdings OCDX
33.4
5. Thermo Fisher Scientific TMO
20.73
6. Mettler-Toledo MTD
20.28
7. Qiagen QGEN
17.3
8. PerkinElmer PKI
16.14
9. Laboratory Corp of America Holdings LH
14.12
10. Agilent Technologies A
13.27
11. Syneos Health SYNH
10.68
12. Myriad Genetics MYGN
10.36
13. Waters WAT
9.79
14. Natera NTRA
8.63
15. Anixa Biosciences ANIX
8.45
16. Heska HSKA
7.67
17. Olink Holding OLK
6.67
18. Trinity Biotech TRIB
6.32
19. IDEXX Laboratories IDXX
6.22
20. Icon ICLR
5.85
21. DexCom DXCM
5.58
22. Exact Sciences EXAS
4.66
23. Sotera Health SHC
4.4
24. Global Cord Blood CO
4.22
25. Sera Prognostics SERA
3.92
26. National Research NRC
3.57
27. Charles River Laboratories CRL
3.4
28. Enzo Biochem ENZ
3.06
29. Psychemedics PMD
3.06
30. Bioventus BVS
2.86
31. Neogen NEOG
2.82
32. Twist Bioscience TWST
2.51
33. NeoGenomics NEO
2.39
34. Guardant Health GH
2.31
35. Fulgent Genetics FLGT
2.27
36. MDxHealth MDXH
2.15
37. Illumina ILMN
2.14
38. MaxCyte MXCT
2.07
39. Exagen XGN
2.06
40. Neuronetics STIM
2.04
41. CareDx CDNA
2.03
42. Inotiv NOTV
2.02
43. Biodesix BDSX
1.86
44. Prenetics Global PRE
1.86
45. Organovo Holdings ONVO
1.79
46. DarioHealth DRIO
1.79
47. bioAffinity Technologies BIAF
1.78
48. Interpace Biosciences IDXG
1.78
49. Co-Diagnostics CODX
1.77
50. Pacific Biosciences of California PACB
1.74
51. Personalis PSNL
1.69
52. Precipio PRPO
1.66
53. SeqLL SQL
1.47
54. Aspira Womens Health AWH
1.38
55. Medpace Holdings MEDP
1.29
56. RadNet RDNT
0.9
57. Lantheus Holdings LNTH
0.77
58. Meridian Bioscience VIVO
0.73

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.